- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07855185
Trapezius Oxygenation and Cervical Function in Chronic Neck Pain
Association Between Trapezius Muscle Oxygenation and Cervical Function in Individuals With Chronic Neck Pain
The aim of this study is to investigate the relationship between trapezius muscle oxygenation and cervical range of motion, muscle strength, and disability in individuals with chronic neck pain.
Studieoversikt
Status
Forhold
Detaljert beskrivelse
Chronic neck pain is a common musculoskeletal condition associated with impaired cervical mobility, reduced muscle performance, and increased disability. Alterations in local muscle oxygenation and microcirculation, particularly in the trapezius muscle, may contribute to persistent symptoms and functional limitations. Near-infrared spectroscopy provides a non-invasive method for assessing muscle oxygenation and hemodynamic responses. This study aims to investigate the relationship between trapezius muscle oxygenation, cervical range of motion, muscle strength, and disability in individuals with chronic neck pain.
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Başak Kavalcı Kol, PhD
- Telefonnummer: +903862802317
- E-post: basak.kavalci@ahievran.edu.tr
Studiesteder
-
-
-
Kırşehir, Tyrkia (Türkiye), 40100
- Kırşehir Ahi Evran University.
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Adults aged 18-65 years with chronic neck pain lasting for at least 12 weeks who meet the study eligibility criteria.
Beskrivelse
Inclusion Criteria:
- Aged 18-65 years.
- Chronic neck pain lasting for at least 3 months.
- Neck pain intensity of ≥3 on the Visual Analog Scale during activity.
- Willingness to participate in the study.
Exclusion Criteria:
- Motor deficit in the upper extremities.
- History of cervical or upper-extremity surgery.
- Rheumatologic or neurologic disease.
- Any musculoskeletal condition affecting upper-extremity function.
- Cervical injection or other invasive procedure within the previous 6 months.
- Cognitive impairment preventing understanding or performance of study assessments.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: COHORT
- Tidsperspektiver: PROSPECTIVE
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Chronic Neck Pain Group
Adults aged 18-65 years with chronic neck pain lasting at least 12 weeks will be included in the study. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Trapezius Muscle Oxygen Saturation
Tidsramme: First Day
|
Trapezius muscle oxygen saturation will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise. |
First Day
|
|
Trapezius Total Hemoglobin
Tidsramme: First day
|
Trapezius total hemoglobin will be assessed using near-infrared spectroscopy monitor during upper-extremity exercise. |
First day
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Trapezius Muscle Strength
Tidsramme: Second Day
|
Upper and middle trapezius muscle strength will be measured using a handheld dynamometer. |
Second Day
|
|
Cervical Range of Motion
Tidsramme: Second day
|
Active cervical flexion, extension, lateral flexion, and rotation will be measured using a goniometer. |
Second day
|
|
Neck Disability
Tidsramme: Second day
|
Disability will be assessed using the Neck Disability Index (NDI; 0-50 points), with higher scores indicating greater disability. |
Second day
|
|
Upper-Extremity Exercise Capacity
Tidsramme: First Day
|
Maximum upper-extremity exercise capacity will be assessed using an arm ergometer test, with peak workload recorded in watts. |
First Day
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- AhiEvranU531
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .